InTandem Capital invests in drug developer Clinilabs

Clinilabs has conducted more than 750 CNS clinical trials since its inception.

12 March 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.